FindTrial
Sign In

wound injection with bupivacaine and dexmedetomidine compared with placebo for post operative pain relief

post operative analgesic effect of infiltration of bupivacaine and dexmedetomidine in surgical wound- A randomised placebo controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/09/007245
Enrollment
90
Registered
2016-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- those undergoing elective open abdominal surgeries

Interventions

Intervention1: dexmedetomidine 1 microgram/kg with 30 ml of 0.25% bupivacaine at the time of closure.: to be infiltrated in surgical wound Control Intervention1: 30 ml of 0.25% bupivacaine at the time

Sponsors

Indira Gandhi Institute of Medical Sciences Sheikhpura Patna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Age 15 to 60 years. • ASA grade I &II • Elective open abdominal surgeries, namely open cholecystectomy, nephrectomy, pyeloplasty.

Exclusion criteria

Exclusion criteria: • Cardiopulmonary diseases • Hepato-renal insufficiency • Patients receiving adrenoceptor agonists, antagonists, narcotics, or NSAIDS prior to surgery. • Raynauds disease • Morbid obesity

Design outcomes

Primary

MeasureTime frame
pain score by visual analogue scoreTimepoint: 24 hours—

Secondary

MeasureTime frame
sedation levelTimepoint: 24 hours—

Countries

India

Contacts

Public ContactDr Swati

Indira Gandhi Institute of Medical Sciences

deepakswat@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026